Overview
Qlucore provides software solutions for precision medicine, including Qlucore Omics Explorer, Qlucore Insights, and Qlucore Diagnostics, enabling multi-omics data analysis, AI-powered machine learning classifiers for disease subtyping, and companion diagnostics development. Their platform supports clinical diagnostics like RNA-seq-based subtype classification for B-cell leukemias (BCP-ALL), certified under IVDR with CE-mark. It facilitates research, drug development, and scalable deployment across cancer types through visualization-based tools and plug-in models.
Frequently asked questions
- What are Qlucore's key software products for pharma R&D and diagnostics?
- Qlucore offers Qlucore Omics Explorer for research data analysis, Qlucore Insights for interpretation, and Qlucore Diagnostics for clinical use, supporting multi-omics, AI classifiers, and companion diagnostics development.
- What regulatory certifications does Qlucore Diagnostics hold?
- Qlucore Diagnostics for BCP-ALL is certified under the IVDR regulation and CE-marked, using RNA-seq for gene expression subtype classification and gene fusion analysis.
- What capabilities does Qlucore provide for precision oncology and companion diagnostics?
- Qlucore enables disease-specific AI-based machine learning classifiers for subtyping, integrated with NGS workflows, visualizations, and report generation for clinical tests and CDx across cancer types.